Analysis in related influencing factors of sarcopenia in patients with maintenance hemodialysis for end-stage renal disease

CAI Qian; ZHANG Zulong

doi:10.7619/jcmp.20230632

Journal of Clinical Medicine in Practice > 2023 > 27(10): 84-90. > DOI: 10.7619/jcmp.20230632

CAI Qian, ZHANG Zulong. Analysis in related influencing factors of sarcopenia in patients with maintenance hemodialysis for end-stage renal disease[J]. Journal of Clinical Medicine in Practice, 2023, 27(10): 84-90. DOI: 10.7619/jcmp.20230632

Citation:

PDF (1319 KB)

Analysis in related influencing factors of sarcopenia in patients with maintenance hemodialysis for end-stage renal disease

CAI Qian,
ZHANG Zulong^,

Department of Nephrology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, 550004

More Information

Received Date: March 01, 2023
Revised Date: May 21, 2023
Available Online: June 06, 2023

Graphical Abstract

Abstract

Abstract

Objective
To explore the related influencing factors of sarcopenia in patients with maintenance hemodialysis (MHD) for end-stage renal disease (ESRD).
Methods
A total of 197 ESRD patients with regular MHD treatment were selected as research objects. Skeletal muscle mass index (SMI) and other body components were measured by bioelectrical impedance method, the grip strength was measured by electronic grip tester, and the general material, anthropometry indicators and blood test indicators were collected. The related influencing factors of sarcopenia in ESRD patients with MHD were analyzed.
Results
The incidence of sarcopenia in 197 ESRD patients with MHD was 36.55% (72/197). There were significant differences in age, dialysis duration, gender, combined with hypertension, body mass index (BMI), thickness of triceps skinfold, grip strength, lean tissue index (LTI), total water of body (TWB), intracellular water (ICW), lean tissue mass (LTM), fat mass (FAT), body cell mass (BCM), fat free mass (FFM), creatinine, β₂ microglobulin, triglyceride and high-density lipoprotein between sarcopenia group (n=72) and non-sarcopenia group (n=125) (P < 0.05). The results of univariate binary Logistic regression analysis showed that advanced age (OR=1.048, P=0.040, 95%CI, 1.021 to 1.078), male (OR=0.371, P=0.001, 95%CI, 0.204 to 0.673), grip strength (OR=0.838, P < 0.001, 95%CI, 0.764 to 0.920) and FFM (OR=0.634, P < 0.001, 95%CI, 0.527 to 0.761) were the influencing factors of sarcopenia in ESRD patients with MHD. Spearman correlation analysis showed that age was negatively correlated with grip strength (r=-0.283, P < 0.001), grip strength was positively correlated with SMI (r=0.455, P < 0.001), FFM was positively correlated with SMI and grip strength (r=0.904, 0.499, P < 0.001), and FFM was negatively correlated with 6-meter walking speed (r=-0.245, P=0.001). The area under the curve (AUC) for diagnosis of sarcopenia in combination of gender, advanced age, grip strength and FFM in ESRD patients with MHD was 0.817 (95%CI, 0.759 to 0.875), with a sensitivity of 100.00% and a specificity of 64.00%.
Conclusion
The incidence of sarcopenia is higher in ESRD patients with MHD, and advanced age, male, grip strength and FFM are the influencing factors of sarcopenia in ESRD patients with MHD. FFM can predict the probability of sarcopenia in ESRD patients with MHD, and its predictive efficacy will be higher when combined with gender, age and grip strength.
- end-stage renal disease,
- maintenance hemodialysis,
- sarcopenia,
- risk factors,
- bioelectrical impedance method,
- skeletal muscle mass index

FullText(HTML)

References (29)

References

[1]	ZIOLKOWSKI S L, LONG J, BAKER J F, et al. Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity[J]. J Cachexia Sarcopenia Muscle, 2019, 10(2): 338-346. doi: 10.1002/jcsm.12396
[2]	FAHAL I H. Uraemic sarcopenia: aetiology and implications[J]. Nephrol Dial Transplant, 2014, 29(9): 1655-1665. doi: 10.1093/ndt/gft070
[3]	杨君红, 梁兰玉, 单清. 慢性阻塞性肺疾病合并肌少症研究进展[J]. 实用临床医药杂志, 2021, 25(3): 120-124. doi: 10.7619/jcmp.20201598
[4]	王焕如, 于翰, 邵晋康. 肌肉减少症研究进展[J]. 中国骨质疏松杂志, 2022, 28(2): 304-307. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZS202202026.htm
[5]	王亚美, 邢利, 程艳, 等. 维持性血液透析患者肌肉减少症的危险因素及预后研究[J]. 中国实用内科杂志, 2020, 40(5): 396-400. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK202005011.htm
[6]	KIM J K, KIM S G, OH J E, et al. Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis[J]. Korean J Intern Med, 2019, 34(3): 599-607. doi: 10.3904/kjim.2017.083
[7]	郭衍超, 王霓雯, 姚颖. 老年肌少症的研究进展[J]. 老年医学与保健, 2020, 26(1): 4-8. https://www.cnki.com.cn/Article/CJFDTOTAL-LYBJ202001002.htm
[8]	CHEN L K, LIU L K, WOO J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia[J]. J Am Med Dir Assoc, 2014, 15(2): 95-101. doi: 10.1016/j.jamda.2013.11.025
[9]	LAI S, MUSCARITOLI M, ANDREOZZI P, et al. Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy[J]. Nutrition, 2019, 62: 108-114. doi: 10.1016/j.nut.2018.12.005
[10]	GIGLIO J, KAMIMURA M A, LAMARCA F, et al. Association of sarcopenia with nutritional parameters, quality of life, hospitalization, and mortality rates of elderly patients on hemodialysis[J]. J Ren Nutr, 2018, 28(3): 197-207. doi: 10.1053/j.jrn.2017.12.003
[11]	何莉, 陈林, 张颖君, 等. 亚洲地区维持性血液透析患者肌少症患病率及影响因素的Meta分析[J]. 中国血液净化, 2021, 20(7): 455-459. doi: 10.3969/j.issn.1671-4091.2021.07.006
[12]	曹世琦, 许贤荣, 冯进, 等. 基于Logistic回归模型分析维持性血液透析患者肌少症的危险因素及其对患者生活质量、负性情绪及生存状况的影响[J]. 现代生物医学进展, 2022, 22(21): 4180-4184, 4111. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202221033.htm
[13]	俞红霞, 孔祥栋. 维持性血液透析患者肌少症发生情况及危险因素调查[J]. 全科医学临床与教育, 2022, 20(10): 933-935. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYL202210018.htm
[14]	王楠, 魏雅楠, 刘杰, 等. 住院老年慢性病患者肌少症的相关影响因素分析[J]. 中国全科医学, 2020, 23(5): 611-616. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202005058.htm
[15]	KITTISKULNAM P, CHERTOW G M, CARRERO J J, et al. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis[J]. Kidney Int, 2017, 92(1): 238-247.
[16]	MORI K, NISHIDE K, OKUNO S, et al. Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis[J]. BMC Nephrol, 2019, 20(1): 105.
[17]	CRUZ-JENTOFT A J, SAYER A A. Sarcopenia[J]. Lancet, 2019, 393(10191): 2636-2646.
[18]	刘勇, 周加军, 高潮清. 肌少症在维持性血液透析患者中的发生率及其相关危险因素分析[J]. 皖南医学院学报, 2022, 41(1): 25-27, 35. https://www.cnki.com.cn/Article/CJFDTOTAL-WNYX202201007.htm
[19]	李兰, 温贤秀, 夏琪, 等. 维持性血液透析患者肌少症患病率的meta分析[J]. 现代预防医学, 2021, 48(22): 4214-4218. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF202122036.htm
[20]	储腊萍, 俞娅芬, 包晓燕, 等. 中老年维持性血液透析患者肌少症发生率及其影响因素[J]. 中国老年学杂志, 2021, 41(15): 3249-3253. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ202115033.htm
[21]	LI C W, YU K, SHYH-CHANG N, et al. Sterol metabolism and protein metabolism are differentially correlated with sarcopenia in Asian Chinese men and women[J]. Cell Prolif, 2021, 54(4): e12989.
[22]	CARRERO J J, QURESHI A R, NAKASHIMA A, et al. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease[J]. Nephrol Dial Transplant, 2011, 26(1): 184-190.
[23]	TSUTSUMIMOTO K, DOIT, NAKAKUBO S, et al. Association between anorexia of ageing and sarcopenia among Japanese older adults[J]. J Cachexia Sarcopenia Muscle, 2020, 11(5): 1250-1257.
[24]	DU Y P, WANG X D, XIE H, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria[J]. BMC Endocr Disord, 2019, 19(1): 109.
[25]	MUSTANOJA S, STRBIAN D, PUTAALA J, et al. Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage[J]. Stroke, 2013, 44(8): 2330-2332.
[26]	LEAL V O, MAFRA D, FOUQUE D, et al. Use of handgrip strength in the assessment of the muscle function of chronic kidney disease patients on dialysis: a systematic review[J]. Nephrol Dial Transplant, 2011, 26(4): 1354-1360.
[27]	梅佳仪, 于洪宇, 夏晓莲. 某市老年肌肉衰减征影响因素分析[J]. 中国现代医学杂志, 2017, 27(10): 85-89. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXDY201710017.htm
[28]	孟宇, 陈勇, 尹良红. 非脂肪组织含量在评价维持性血液透析患者营养状态及短期预后中的作用[J]. 肾脏病与透析肾移植杂志, 2011, 20(6): 517-521. https://www.cnki.com.cn/Article/CJFDTOTAL-SZBY201106005.htm
[29]	戴祺洁, 陶静, 华建武, 等. 维持性血液透析患者肌少症发生情况及其影响因素分析[J]. 实用临床医药杂志, 2020, 24(12): 103-106. doi: 10.7619/jcmp.202012029

[1]	WANG Jie, GU Ting, SONG Jixin, WU Yinqiu, DAI Chun, DAI Hua. Effects of human adaptor protein LNK on proliferation and invasion ability of non-small cell lung cancer cells[J]. Journal of Clinical Medicine in Practice, 2023, 27(10): 31-35. DOI: 10.7619/jcmp.20230166
[2]	TIAN Ling. Effect of Urinary Kallidinogenase for Injection on nervous function in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2020, 24(8): 101-103. DOI: 10.7619/jcmp.202008027
[3]	REN Kaiming. Influence of long non-coding RNA KCNQ1 overlapping transcript 1 on cellular proliferation, migration and invasive ability of lung squamous cell carcinoma[J]. Journal of Clinical Medicine in Practice, 2019, 23(9): 1-4, 8. DOI: 10.7619/jcmp.201909001
[7]	ZHU Jinli. Effect of urinary kallidinogenase combined with troxerutin and cerebroprotein hydrolysate injection on coagulation and neurological function of patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2016, (9): 17-20. DOI: 10.7619/jcmp.201609005
[9]	MENG Yun, XHOU Hongbin, XHU Yanliang. Influence of arterial thrombolysis combined with urinary kallidinogenase on the prognosis of patients with acute posterior circulation cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2014, (9): 51-54. DOI: 10.7619/jcmp.201409014
[10]	LIU Zhenqi, ZHENG Ying. Impact of urinary kallidinogenase to NIHSS scores in patients with cerebral watershed infarcts[J]. Journal of Clinical Medicine in Practice, 2012, (21): 90-91,96.

Cited By

Cited by

Periodical cited type(1)

吴艳，相开放. 甲状腺乳头状癌组织中MTAP、SETD2表达水平及其与临床病理特征的关系. 黑龙江医药. 2023(03): 704-706 .

Other cited types(1)

Get Citation

PDF

XML

Article views (178) PDF downloads (17) Cited by(2)

Turn off MathJax

Article Contents

Abstract

References

Analysis in related influencing factors of sarcopenia in patients with maintenance hemodialysis for end-stage renal disease